#ATA2025 highlights 🦋: active surveillance/ablation for ≤1 cm low-risk tumors, updated Tg cutoffs and de-escalation in follow-up, neoadjuvant RET-targeted therapy, AI-enhanced ultrasound, immunotherapy advances, and care disparities spotlighted. 🙌 @AmThyroidAssn
CAREER NEWS: Happy to share I have joined the @universityofky.bsky.social @ukhealthcare.uky.edu in beautiful 🐎 Lexington KY, where I'll have the privilege of leading the #ThyroidCancer Program @ukmarkey.bsky.social & continue my passion for #MedEd serving as endo fellowship APD #GoWildcats 😺
After 7 incredible years, I’m saying goodbye to @MayoClinic @MayoClinicHS. Grateful for the mentorship, growth, and countless lessons that shaped me into the doc I am today. This is a place that challenged and prepared me well for what’s next and I am so thankful @MayoClinicEndo
🧵 The USPSTF's latest guidelines on screening for #osteoporosis now defines screening as a specific method of x-ray bone density testing.
JAMA provides clinicians with essential resources to understand & implement these updated guidelines.
ja.ma/4aoKGWE
#MedSky
2️⃣ 20 y/o male
🚭 Non-smoker (0 pts)
FT4: 2 ng/dL (+15 pts)
Age: 20 years (+7.6 pts)
⏰ of ATD: 24 months (+30 pts)
🔢 Total: 73.6 pts ➡️ 30% risk
📊A tool to personalize GD treatment decisions! Future research to validate this prospectively in larger cohorts!
#MayoClinicEndocrinology
You see the following patient in your clinic.
1️⃣ 40 y/o female (+25 pts)
Smoker 🚬 (+18.7 pts)
FT4: 4 ng/dL (+30.1 pts)
Age: 40 years (+25 pts)
Duration ⏰ of ATD: 12 months (+41 pts)
🔢 Total: 122 pts ➡️ 70% risk
Compare this to patient #2 (see 👇)
📊 Our nomogram integrates these and other variables, guiding personalized treatment decisions!
What is this patient's risk of recurrence? Examples using the full Graves' Disease nomogram (see 👇)
📈 Key findings that increase recurrence risk:
Age: Each decade increases risk by 31% (HR 1.31).
Baseline Free T4: Every 2.0 ng/dL rise boosts risk by 65% (HR 1.65).
Continued 👇
Ringing in the new year with publication in Endocrine Practice!
Our study🔍 introduces a predictive model for Graves' disease recurrence after antithyroid therapy 💊, featuring a nomogram for bedside clinical use. 🏥 (thread ⬇️)
tinyurl.com/58uufx3u
#GravesDisease #Endocrinology #PrecisionMedicine
